PCNA and lip and oral cavity carcinoma: Wang et al. (2019) [48] sought to evaluate the capability of MEHP to promote the proliferation of oral cancer through an in vitro/in vivo study using human oral squamous carcinoma (OSCC) (human OSCC SCC-4, SCC-9, and SCC-25) cells and cell nuclear antigen (PCNA).